laughing couple

The Future of Diagnostics Now.

At Metabolomic Technologies, we are committed to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs.

Learn More


Unique Powerful Platform.

There are more than 40,000 small molecule metabolites in the human body. Through the identification of distinct, metabolic fingerprints, we are developing groundbreaking diagnostics.

See our products

A message from our CEO

The strength of our company is in our proprietary technology and our award-winning leadership team. We are focused on bringing our simple, effective solution to market to help manage the disease of colorectal cancer.

Milestone Timeline


1000-Patient Discovery Trial Completed


Validation Trials Completed


2M CAD Seed Round


PolypDx™ LDT Launched


Canadian Assessment of PolypDx™


2018 Economic Model showing PolypDx™ is cost-effective


US Patent Issued - Completing global IP coverage


Discovery & Validation on additional CRC markers


Closed 3.2M USD Series A Round

Haili Wang AsTech Award 7

7 awards in 7 years

We are proud to share the recognition that we've received from people who know a good thing when they see it.

View All Awards

Our Partners

View All
Met some great students at the University of Alberta today. #AIMSS2020Symposium

Interested in partnering with us?

Contact Us